Answers are grounded in this paper and cite their sources.
Research demonstrates changes in volume of distribution in acidic drugs, implying mechanisms for improved therapeutic outcomes.
Acidic drugs generally have small steady-state volumes of distribution (Vss) around 0.1-0.25 L/kg, due to high binding to serum albumin and low binding to phospholipids in tissues. Acids can reach pharmacological targets in tissues despite small Vss. Enterohepatic recirculation (EHR) of parent drug or reversible acyl glucuronide can increase the Vss of acids. However, rational design to incorporate EHR as a mechanism to increase Vss remains challenging because of the complexity of EHR and lack of reliable predictive tools. Uptake transporters can increase the Vss of acidic drugs by increasing the liver drug concentration and can facilitate EHR through enhancing biliary elimination and glucuronide formation. Half-life extension of acids mainly relies on reducing clearance or using modified release formulations rather than modulating Vss.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: